Validation of PON1 enzyme activity assays for longitudinal studies

被引:61
作者
Huen, Karen [1 ]
Richter, Rebecca [2 ]
Furlong, Clement [2 ]
Eskenazi, Brenda [1 ]
Holland, Nina [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Ctr Childrens Environm Hlth, Berkeley, CA 94720 USA
[2] Univ Washington, Div Med Genet, Dept Genome Sci & Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
Paraoxonase; Arylesterase; PON1; activity; Enzymatic assay; Children; Storage; Technical variability; Temperature; Organophosphate; Pesticides; Oxidative stress; Freeze-thaw; Birth cohort; ORGANOPHOSPHATE PESTICIDE EXPOSURE; INFLAMMATORY-BOWEL-DISEASE; HUMAN SERUM; PARAOXONASE PON1; GENE POLYMORPHISMS; OXIDATIVE STRESS; MOLECULAR EPIDEMIOLOGY; ASSOCIATION; CHILDREN; PREDICTOR;
D O I
10.1016/j.cca.2008.12.019
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: Paraoxonase (PON1) enzymatic activity assays are used to characterize sensitivity to organophosphates and oxidative stress. Length of sample storage, temperature and other factors may influence variability of PON1 measurements, especially in longitudinal studies. Methods: Effects of assay temperature, storage duration up to 7 y (-80 degrees C), freeze-thaw cycles, the type of specimen (serum or heparinized plasma) and assay variability were evaluated for 4 PON1 substrate-specific assays using samples from two pediatric cohorts and laboratory volunteers. Results: Intra- and inter-assay variation, as well as inter-laboratory variability for PON1 activities were <10%. The effect of storage duration up to 2 y was minimal. However, after 7 y, arylesterase, paraoxonase, and chlorpyrifos-oxonase activities decreased more noticeably. Similarly, while freeze-thaw cycles did not affect the PON1 activities in samples stored <2 y, this factor was more significant after 7 y for arylesterase. Assay temperature and specimen type also influenced PON1 measurements. Conclusions: Sources of technical variability of PON1 activity assays, including storage duration, freeze-thaw, and temperature should be monitored and minimized through study design, quality control procedures and statistical methods, especially in longitudinal studies where specimens may be stored for years prior to analysis. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 41 条
[1]
[Anonymous], 2008, Cell Preservation Technology, V6, P3, DOI DOI 10.1089/CPT.2008.9997
[2]
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development [J].
Aviram, M ;
Rosenblat, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) :1304-1316
[3]
In utero pesticide exposure, maternal paraoxonase activity, and head circumference [J].
Berkowitz, GS ;
Wetmur, JG ;
Birman-Deych, E ;
Obel, J ;
Lapinski, RH ;
Godbold, JH ;
Holzman, IR ;
Wolff, MS .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2004, 112 (03) :388-391
[4]
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk [J].
Bhattacharyya, Tamali ;
Nicholls, Stephen J. ;
Topol, Eric J. ;
Zhang, Renliang ;
Yang, Xia ;
Schmitt, David ;
Fu, Xiaoming ;
Shao, Mingyuan ;
Brennan, Danielle M. ;
Ellis, Stephen G. ;
Brennan, Marie-Luise ;
Allayee, Hooman ;
Lusis, Aldons J. ;
Hazen, Stanley L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11) :1265-1276
[5]
BRACKLEY M, 1983, RES COMMUN CHEM PATH, V41, P65
[6]
Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay [J].
Browne, Richard W. ;
Koury, Stephen T. ;
Marion, Susan ;
Wilding, Gregory ;
Muti, Paola ;
Trevisan, Maurizio .
CLINICAL CHEMISTRY, 2007, 53 (02) :310-317
[7]
Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate [J].
Charlton-Menys, V ;
Liu, YF ;
Durrington, PN .
CLINICAL CHEMISTRY, 2006, 52 (03) :453-457
[8]
Haplotype-phenotype relationships of paraoxonase-1 [J].
Chen, J ;
Chan, W ;
Wallenstein, S ;
Berkowitz, G ;
Wetmur, JG .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :731-734
[9]
Expression of human paraoxonase (PON1) during development [J].
Cole, TB ;
Jampsa, RL ;
Walter, BJ ;
Arndt, TL ;
Richter, RJ ;
Shih, DM ;
Tward, A ;
Lusis, AJ ;
Jack, RM ;
Costa, LG ;
Furlong, CE .
PHARMACOGENETICS, 2003, 13 (06) :357-364
[10]
Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma [J].
Connelly, Philip W. ;
Maguire, Graham F. ;
Picardo, Clive M. ;
Teiber, John F. ;
Draganov, Dragomir .
JOURNAL OF LIPID RESEARCH, 2008, 49 (01) :245-250